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THE  SPECIFICITY  OF  T-CELL  HELPER  FACTOR IN  MAN* 
BY RAIF S.  GEHA, FUAD MUDAWWAR,  AND EVELINE SCHNEEBERGER 
(From the Departments  of  Pediatrics and Pathology, Harvard Medical School, and the Divisions of 
Allergy and Immunology, the Department  of Medicine and Department  of Pathology at the 
Children's  Hospital  Medical Center, Boston,  Massachusetts  02115) 
A variety of helper factors necessary for in vitro antibody response by B cells 
have been identified in the supernates of antigen-stimulated  T  cells of experi- 
mental  animals  (1-6).  These factors fall into two broad categories: nonspecific 
helper factors (1-4), and antigen specific helper factors (5, 6). Nonspecific factors 
of T-cell  origin  behave like polyclonal B-cell activators  and  stimulate  synge- 
neic as well as allogeneic B cells to synthetize antibodies against a  variety of 
antigens  (1-3).  On the other hand  antigen-specific factors induce only autolo- 
gous B cells (or B cells that share a  haplotype or Ia determinants  with autolo- 
gous B cells) to synthetize antibodies with specificity restricted to the antigen 
used to elicit the T-cell helper activity.  It has  also been shown that  antigen- 
specific factors express Ia determinants  and contain or can bind to antigen or 
antigen fragments  (5, 6). 
Supernates  of human  T  cells stimulated  with tetanus  toxoid antigen  (TT) 1 
have  been  shown to  contain  a  helper  factor(s)  termed  lymphocyte mitogenic 
factor (LMF) which can induce blastogenesis and immunoglobulin synthesis in 
as many as 50-60% of autologous as well as allogeneic B cells (7). A fraction (10- 
20%) of the IgG secreted was shown to have specificity against TT. The specific- 
ity of human T-cell derived LMF is examined in this paper. 
Materials  and  Methods 
Antigens and Antibodies.  TT and diphteria toxoid (DT) were a gift from Dr. Leo Levine of the 
Massachusetts Biological Laboratories. These antigens were purified by Sephadex G 200 chroma- 
tography (8). (Pharmacia Fine Chemicals Inc., Piscataway, N.J.) In both instances more than 90% 
of the purified material was precipitable by the corresponding specific rabbit antiserum. Strepto- 
kinase-streptodornase antigen was obtained from The Lilly Research Laboratories Eli Lilly and 
Co.,  Indianapolis,  Ind.;  Monilia antigen  was  obtained  from  Hollister-Stier Laboratories  Inc., 
Yeadon, Pa.; and keyhole limpet hemocyanin (KLH) was purchased from Sigma Chemical Co., St. 
Louis,  Mo. Antigens were dialyzed against tissue culture medium before use.  Iodination of TT, 
DT, and KLH was carried with carrier-free iodine 125I by the chloramine-T method (9). Anti-TT 
and anti-DT antisera were raised in rabbits immunized with these antigens in complete Freund's 
adjuvant.  Antibody titers were determined by hemmagglutination of sheep erythrocytes coated 
* Supported by U. S. Public Health Service grants AI 11419, AI 05877, and AM 16392. 
' Abbreviations  used in this paper: B cell, non-thymus-derived lymphocyte, BSA, bovine serum 
albumin; DT, diphteria toxoid;  KLH, keyhole limpet hemocyanin; LMF, lymphocyte mitogenic 
factor;  LMF-DT,  LMF prepared  by  using  DT  antigen;  LMF-TT,  LMF prepared  by  using TT 
antigen;  M199-HSA,  medium  199  with  1%  human  serum  albumin;  MI,  mitogenic index;  P, 
preincubated; R, reconstituted; SKSD, streptokinase-streptodornase, T cell, thymus-derived lym- 
phocyte;  TT, tetanus toxoid. 
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with antigen by using chromic chloride (10). They were 1/16,000 and 1/8,000 for the anti-TT and the 
anti-DT antisera, respectively. Rabbit anti-human IgG and anti-human IgM antisera specific to 
heavy chains were obtained from Behring Diagnostics, American Hoechst Corp., Somerville, N. J. 
Immunoadsorbents.  TT and DT antigens were cross-linked to Sepharose 4B and to Sepharose 
6MB beads (Pharmacia Fine Chemicals, Inc.) by the cyanogen bromide activation method of Axen 
and Ernback (11). The IgG fraction from rabbit anti-human IgG, from rabbit anti-human IgM, and 
from rabbit anti-TT antiserum was purified by diethylaminoethylcellulose (DEAE 32, Whatmann 
Chemicals, Div. W & R Balston, Maidstone, Kent, England) chromatography by using a 0.01-M, 
pH  6.8 phosphate buffer as  eluting buffer.  The purified IgG was then dialyzed against 0.1  M 
NaHCO3  and corss-linked to Sepharose beads.  The efficiency of protein coupling to Sepharose 
beads exceeded 80% in all instances. 
Preparation  of Lymphocytes.  Mononuclear  cells  were  isolated  from  heparinized  blood  on 
Ficoll-Hyapque  gradients or by the means of an IBM cell separator  (Haemonetics,  model  10, 
Haemonetics Corp., Natick, Mass.). 90% of the cells were mononuclear and viability exceeded 90% 
as determined by trypan blue exclusion. Mononuclear cells were washed three times before use 
with medium 199 (Microbiological Associates, Rockville, Md.). Tonsil lymphecytes were obtained 
by mincing the tonsils with forceps and scissors, sedimenting the debris, and passing the cell-rich 
suspension over a  column of glass beads prewarmed to 37°C  (12). 
Preparation of B  Lymphocytes.  Lymphocyte  suspensions rich  in  B  cells  were  obtained by 
fractionating tonsil or blood lymphocytes on gradients of 17-35% bovine serum albumin (BSA), as 
described previously (7), and taking the cells that sediment in fraction 7 of the gradient (interface 
of 29-31% BSA). About 80-90% of the cells in this fraction carry membrane-bound immunoglobu- 
lins and form rosettes with EAC1423. 
Preparation of  B Cells Enriched in Specific Antigen Binding Cells.  5 ml Sepharose 6MB beads 
cross-linked to antigen (DT or TT) were packed into a column in a  10-ml syringe over a support of 
glass wool. The column was placed at 4°C and washed extensively with medium 199 containing 1% 
human serum albumin (M199-HSA). 5 ml of a B-cell suspension at a concentration of 4 x  10  ~ cells/ 
ml in M199-HSA were applied to the column and the cell suspension was allowed to stay in contact 
with the beads for 2 h, after which the column was washed with a  large volume (100 ml) of cold 
M199-HSA. 4-ml fractions were collected from the column eluate. The cells that eluted in the first 
five tubes were  pooled  and washed.  The column was then washed with 50 ml of medium  199 
containing antigen (TT or DT) at a concentration of 200/~g per ml and the cells eluted (1-2% of the 
starting cell number) with the antigen containing medium were collected and washed. Total cell 
recovery from the column averaged 70-80% and viability exceeded 90% as determined by trypan 
blue exclusion. 
Tissue Culture.  Lymphecytes were cultured in medium  199 or  medium RPMI-1640  (Grand 
Island Biological Co., Grand Island, N. Y.) supplemented with 15% heat inactivated human serum 
obtained from donors with type AB, Rh  ÷ erythrocytes. Cultures were supplemented with penicillin 
G (50 U/ml), streptomycin (50/~g/ml), kanamycin (50 ~g/ml), and Mycostatin (50 ~g/ml). Cultures 
were placed in a  humidified incubator at 37°C in an atmosphere of 5% CO2 in air. 
Production  of T-Cell  Supernates.  The  basic  design  for  production  of T-cell  supernates  is 
described in reference 6. Peripheral blood lymphocytes were cultured at a concentration of 1 x  107 
cells/ml for 3 days. One set of cultures received antigen (TT 5-10/~g/ml; or DT 5-10/~g/ml) at the 
onset of the incubation period and were designated as preincubated (P) cultures. A duplicate set of 
cultures received an equivalent amount of antigen at the end of the incubation period and were 
designated reconstituted (R) cultures. The incubation was terminated by pelleting the cells (200 g 
for 10 rain). Supernates were collected, filtered through a 0.22-~m filter (Millipore Corp., Bedford, 
Mass.), and stored at -20°C until tested. 
Fractionation  of T-Cell Supernates  on  Sephadex  G  200.  50  ml  of T-cell  supernates  were 
concentrated fivefold by ultrafiltration by using an Amicon XM50 membrane  (Amicon Corp., 
Lexington, Mass.) then applied to a  1.5 x  100-cm G 200 column equilbrated in 0.15 M NaC1. The 
material eluting after albumin but before free salts (fraction IV of Sephadex G 200 eluate) was 
collected,  dialyzed  against water,  and  concentrated by embedding the  dialysis tubing  in  dry 
Sephadex G 200. The concentrated material was diluted 1:2 in medium RPMI-1640 (Grand Island 
Biological Co.) containing 5% human serum albumin and designated LMF-TT (fraction IV). 
Depletion of T-Cell Supernates from Antigen.  Crude T-cell supernates as well as Sephadex G 
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columns. 5 ml of Sepharose 4B beads cross-linked to anti-TT were packed into a column in a  10-ml 
syringe plugged with glass wool. The column was washed extensively with culture medium, then 
5  ml  of supernates  were  applied to  the  column.  After an incubation period of 2  h  at  4°C  the 
supernates were eluted from the column and millipore filtered. Parallel experiments were carried 
where l~SI-labeled TT was added to the supernates to ascertain the extent of antigen depletion. 
Less than 0.1% of the radioactivity was eluted from the column. In some experiments Sephadex G 
200 fractionated supernates were passed  sequentially through TT  and anti-TT-immunosorbent 
columns. 
Assay of T-Cell Supernates on B Lymphocytes 
MITOaE~rESIS.  B lymphocytes were cultured in 0.2-ml cultures in the wells of microtiter plates 
(Falcon Plastics, Oxnard, Calif.) at a concentration of 1 x  10  e cells/ml and in various dilutions ofT- 
cell supernates. After an incubation period of 6 days the degree of [3H]thymidine incorporated into 
DNA was determined by using a tissue culture automatic harvester (Skatron, Flow Laboratories, 
Inc., Rockville, Md.). Results were expressed as counts per minute of [~H]thymidine incorporated 
per culture and as mitogenic index (MI) where 
MI =  cpm of [3H]thymidine incorporated in P-stimulated culture 
cpm of [~H]thymidine incorporated in R-stimulated culture 
IMMUNOGLOBULIN SYNTHESIS.  B lymphocytes were cultured at 2 ×  l0  s cells/ml in 16 x  125-mm 
sterile Falcon plastic culture tubes (Falcon Plastics) in the presence ofT-cell supernates. After a 5- 
day incubation period,  cell pellets were thoroughly washed in Hank's medium and then resus- 
pended at 4  x  106/ml  in fresh RPMI-1640 medium  (Grand Island Biological Co.) deficient in L- 
valine,  L-leucine, and L-isoleucine, and supplemented with C14-radioactive amino acids (2 ~Ci/ml) 
and with dialyzed fetal calf serum (Microbiological Associates) 48 h later the supernates of these 
cultures were harvested, filtered through a  0.22-~m Millipore filter, (Millipore Corp.) and frozen 
at -20°C until tested. 
Determination of De Novo Synthesis of  Immunoglobulins.  Newly made IgG, present in super- 
nates of B-cell cultures, was determined by a sandwich radioimmunoassay by using 20/~g human 
IgG  and  rabbit  anti-human IgG  at  equivalence.  The  precipitate  was  washed  three  times  in 
phosphate-buffered saline and redissolved twice in 0.1 N acetic acid and reprecipitated each time 
with  an  equal  volume  of 0.1  N  sodium  hydroxide.  This  procedure  minimizes the  amount  of 
radiolabeled material trapped nonspecifically in the immune precipitate. Precipitates were finally 
dissolved in 0.1 N NaOH and their radioactivity was counted in a liquid scintillation counter (Tri 
Carb,  Packard  Instrument  Co.,  Inc.,  Downers  Grove,  Ill.)  by  using  Aquasol  (New  England 
Nuclear,  Boston,  Mass.)  for  scintillation fluid.  Controls  consisted  of supernates  of fibroblast 
cultures grown in medium containing radioactive amino acids. 
Determination of De Novo Synthesis of Specific IgG Antibodies.  Antibodies of the IgG class, 
specific for TT and DT, were determined by two different methods. The first method consisted of a 
direct coprecipitation: to 0.1 ml of supernate an equivalent amount of antigen (200 ~g of TT or DT) 
and of antigen-specific rabbit antibody (rabbit anti-TT or rabbit anti-DT) were added. The amount 
of radioactivity present in the precipitate was determined. Specifically precipitated radioactivity 
was  obtained by  substracting the  radioactivity  precipitated in  an unrelated  antigen-antibody 
system (ovalbumin-antiovalbumin). 
The  second  method  consisted of adding  to  0.1 "ml of supernates,  0.1  ml  of 12sI radiolabeled 
antigen (30,000 cpm), carrier human IgG,  and an equivalent amount of rabbit anti-human IgG 
preabsorbed with antigen cross-linked to Sepharose 4B. 
Electron Microscopy.  Cell pellets of lymphocytes were fixed in 2% glutaraldehyde in 0.1  M 
cacodylate buffer, pH 7.4, containing 0.1 M sucrose, and 4.5  ×  10 -~ M CaC12 for 1 h  at 4°C.  They 
were rinsed three times in 0.1 M cacodylate buffer, pH 7.4 containing 0.1 M sucrose and postfixed 
in 2% aqueous OsO4 for 1 h at 4°C. The cells were stained en bloc with 1.5% uranyl acetate in 0.05 
M maleate buffer, pH 6.2, and dehydrated in graded ethanol and embedded in Epon. Thin sections 
were cut with a diamond knife (Dupont Instruments, Wilmington, Del.) on an LKB Ultratome III 
(LKB Instruments, Inc., Rockville, Md.) and picked up on carbon coated grids. They were stained 
with lead citrate and examined in a  Philips 300 electronmicroscope (Philips Electronic Instru- 
ments, Inc., Mount Vernon, N,  Y.).  Between 50 and 200 cells were counted from each cell pellet 
which had been incubated with varying concentrations of LMF.  The size of the lymphocytes was R.  S.  GEHA,  F.  MUDAWWAR,  AND  E.  8CHNEEBERGER 
TABLE  I 
Response of B Cells from TT-Immune and TT-Nonimmune Donors to 
LMF-TT 
1439 
Source of B cells  MI 
Total IgG syn-  IgG anti-TT 
thesis*  synthesis* 
A(P-R) 14C cpm  A(P-R) ~4C cpm 
TT-immune donors 
1  62.3  +  8,548  +  1,171 
2  31.5  +  7,206  +  1,015 
3  40.7  +  5,374  +  884 
TT-nonimmune donors 
1  39.5  +  4,316  +  54 
2  23.3  +  5,660  -  115 
3  55.8  +6,323  +  70 
* IgG synthesis was determined on 0.1-ml portions from supernates of B-cell 
cultures containing 4  x  10  ~ cells/ml and therefore correspond to the IgG 
secreted by 4  ×  105 B cells. 
roughly estimated at a  primary magnification of 6,800  by observing whether their borders fell 
within the perimeter of 4 cm diameter circle inscribed on the fluorescent screen of the electron 
microscope. At the above magnification 4 cm represent an actual length of 6 ~m. Small lympho- 
cytes did not extend beyond the borders of the above circle while large lymphocytes had substan- 
tially greater diameters. 
Results 
Effect of T-Cell Supernates on B Cells From TT-Immune and TT-Nonimmune 
Donors.  Lack of immunity to  TT  was  ascertained in  three  individuals by 
negative history for TT immunization, absence of lymphocytes transformation 
in response to TT, and absence of anti-TT antibodies in the serum as determined 
by hemagglutination (10). When B-cell cultures obtained from TT immune and 
TT  nonimmune donors were  incubated in  an equal  volume of fresh culture 
medium  and  of T-cell  supernates,  containing LMF-TT,  an  equal  degree  of 
blastogenesis and of  IgG synthesis was observed. However, only B cells from TT- 
immune donors made IgG with specificity to TT (Table 1). 
Effect  of Antigen  Depletion  on  the  Activity  of T-Cell  Supernates.  When 
LMF-TT was depleted of TT by passage through an anti-TT immunosorbent 
column the same degree of mitogenesis and IgG synthesis was observed in B-cell 
cultures as with LMF-TT not depleted of TT.  No TT-specific antibodies were 
detected in the  supernates of B-cells cultures when the antigen was absent. 
Anti-TT antibodies were only detected if TT were readded to the B-cell cultures 
(Table II). 
Similar findings were obtained when LMF-TT was fractionated on Sephadex 
G 200. The activity of the material eluted after albumin, LMF-TT (fraction IV), 
remained undiminished after sequential passage over TT and anti-TT immuno- 
sorbent columns (Table II). 
Effect of anti-~ and anti-  T Chain Immunosorbents on LMF Activity.  LMF- 
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TABLE  II 
Effect of  Antigen Depletion on the Activity of  LMF-TT on B-Cell Cultures from Immune 
Donors 
Antigen present  IgG  IgG anti-TT*  Source of  Passage over  in B-cell  MI 
supernate  immunosorbent  cultures  synthesis*  synthesis 
A(P-R) ~4C cpm 
LMF-TT  -  TT  78.7  +  7,150  +  1,105 
LMF-TT  anti-TT  -  66.5  +  6,732  +  47 
LMF-TT  anti-TT  TT  65.3  +  6,880  +  810 
LMF/TT fraction IV  -  -  38.3  +  4,067  +  110 
LMF-TT fraction IV  anti-TT  -  32.8  +  3,712  -  30 
LMF-TT fraction IV  anti-TT  TT  30.5  +  4,312  +  677 
* IgG synthesis was determined on 0.1-ml portions from supernates of B-cell cultures containing 4 
×  10  ~ cells/ml and therefore correspond to the IgG secreted by 4  ×  105 B  cells. 
TABLE  III 
Effect of Anti-re and Anti- T Immunosorbent Columns on the 
Activity of LMF-TT on B-CeU Cultures 
Supernatant source 
IgG synthesis* 
Passage over ira-  MI 
munosorbent  A(P-R)  14C cpm 
LMF-TT fraction IV  -  40.3  +  3,990 
LMF-TT fraction IV  anti-/~ chain  33.6  +  3,572 
LMF-TT fraction IV  anti-T chain  37.5  +  3,445 
LMF-TT fraction IV  anti-HSA  34.8  +  3,724 
* IgG synthesis was determined on 0.1-ml portions from supernates of B- 
cell cultures containing 4  x  l0  s cells/ml and therefore  correspond to 
the IgG secreted by 4  ×  l0  s B  cells. 
columns. These passages did not affect the mitogenic activity of LMF-TT nor its 
capacity to induce IgG synthesis in B-cell cultures (Table III). 
Antibody  Synthesis  Against  an  Unrelated  Antigen  Added  to  the  B-Cell 
Culture.  B cells incubated with LMF-TT in the presence of a  second antigen 
DT, made IgG antibodies to DT provided the B-cell donor was immune to that 
antigen (Table IV).  When KLH was used as a  second antigen,  antibodies to 
KLH were not detected. In all cases the B-cell donors were immune to DT but 
not to KLH. Similar findings were true for both unfractionated and fractionated 
T-cell supernates. 
Dose-Response  Curve  of B  Cells  to  Various  Dilutions  of  T-Cell  Super° 
nates.  Fig.  1 shows the dose-response curve of B cells to various dilutions of 
LMF-TT T-cell supernates in fresh culture medium. Optimal mitogensis of B 
cells was induced by a  50% concentration of LMF-TT. Maximal IgG synthesis 
occurred in cultures incubated with a  20%  concentration of LMF-TT.  These 
results correlated with electron microscopic examination of cell pellets. The per 
cent of large blast cells was highest (35%) in pellets of cultures made with 50% 
LMF  (Table  V).  These  pellets  contained many mitotic figures but  very few R.  S.  GEHA~  F.  MUDAWWAR~  AND  E.  SCHNEEBERGER  1441 
TABLE  IV 
Effect of the Addition of a Second Antigen on Specific Antibody Synthesis by B-Cell 
Cultures Stimulated with LMF-TT 
Source of  Antigen present 
T-cell  in B-cell 
supernate  cultures* 
IgG synthesis by B-cell  cultures$ 
Total IgG  anti-TT  anti-DT  anti-KLH 
A(P-R) 
cpm C"  A(P-R) cpm 1  I~ 
LMF-TT  TT  8,077  3,073  128  212 
LMF-TT  TT,  DT  8,345  2,688  1,077  259 
LMF-TT  TT,  KLH  8,212  2,839  307  184 
LMF°DT  DT  6,033  261  1,854  - 
LMF-DT  DT, TT  6,533  1,926  1,665  - 
* B cells  were derived from donors immune to TT and DT but not to KLH. 
IgG synthesis was determined on 0.1-ml portions  from supornates of  B-cell  cultures  containing 4 
× 10  e  cells/ml  and therefore  correspond to  the IgG secreted by 4 × 10  5  B cells. 
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FIe. I.  DNA  synthesis and IEG synthesis induced in B cells  by various concentrations of 
LMF-R~r supernates in fresh  culture  medium. IgG and anti-Tr were determined on 0.1-ml 
aliquots from the supernates  of 4  x  10  e B  cells/ml stimulated  with paired  P  and R 
supernates and the results  are expressed as  A(P-R) C  14  cpm. MI, mitogenic index as  defined 
in the text. 
plasma  cells  (<1%).  Pellets from  cultures  incubated  with  10%  LMF-TT con- 
tained a high proportion (11%) of plasma cells and fewer large blast cells (21%). 
High  concentrations  (>50%)  of T-cell  supernates  became inhibitory  to  B-cell 
responses.  At low concentrations  of LMF-TT  (10%)  the proportion  of antigen- 
specific  antibodies  (anti-TT)  over total  IgG  increased  (Fig.  2).  The  absolute 
amount  of anti-TT  antibodies  remained  rather  constant  until  extremely low 
dilution of T-cell supernates were used (1%). 
At low concentration of LMF-TT (10%) addition of one or more antigen to the 
B-cell cultures caused an increase in the amount of DNA synthesis provided the 
B-cell donor was immune to those antigens  (Table VI). 
Sensitivity  of B-Cell Population  Specifically  Enriched for Antigen-Binding 
Cells.  B-cell populations  enriched  for TT binding  cells exhibited  a  vigorous 1442  THE  SPECIFICITY  OF  T-CELL  HELPER  FACTOR  IN  MAN 
TABLE  V 
Morphology of Lymphoid Cells in B-Cell Cultures Incubated with 
Different  Concentrations of T-Cell Supernates  as Determined  by 
Electron  Microscopy 
Concentration  Large lympho-  Small lympho-  Plasma cells 
of LMF-TT  cytes blasts  cytes 
%  %  %  % 
50  35  65  <0.4 
10  21  68  11.0 
5  23  74  3.1 
1  13  84  2.8 
0  4  96  <0.5 
~  70 
N  60 
~-  5o 
4o 
c  30  < 
20 
~  10 
0  I  I  I  I  I  I  i  I  I  I  I  f 
5  10  20  30  40  50  60  70  80  90  100 
% LMF-TT 
FIG.  2.  Fraction of newly made IgG that has specificity against TT as a  function of the 
concentration of LMF-TT used to stimulate B-cell cultures. 
mitogenic and IgG synthetic response to low concentrations of LMF-TT which 
are normally nonmitogenic for unfractionated B cells (Table VII). This vigorous 
response was not due to nonspecific activation of the TT antigen binding cells as 
these cells failed to respond to equally low concentration of LMF-DT.  At all 
concentrations of LMF-TT more anti-TT antibodies were secreted by TT binding 
B cells than by unfractionated B cells. B cells that eluted from the TT-immuno- 
sorbent  column  failed  to  secrete  anti-TT  antibodies  but  secreted  normal 
amounts of anti-DT antibodies when incubated with LMF-DT. 
Discussion 
The experiments described in this paper demonstrate that supernates of TT- 
activated human T lymphocytes contain a  helper factor for B cells that is not 
antigen specific. This factor, termed LMF, induces DNA and immunoglobulin 
synthesis in autologous as well in allogeneic B cells and in B cells of  TT immune 
as well as of TT nonimmune donors. LMF is active in the absence of antigen 
(TT) and does not contain immunoglobulin determinants. 
The nonspecific nature of LMF was suspected very early in our studies (7) 
because it induced DNA synthesis in a large proportion of B cells (50-60%) and 
was equally active on  autologous as  well  as on allogeneic B  cells,  while all R.  S.  GEHA,  F.  MUDAWWAR,  AND  E.  SCHNEEBERGER 
TABLE VI 
Effect of Addition of Antigens to B-Cell Cultures Stimulated with Various 
Concentrations  of LMF-TT 
1443 
Source and con-  Mitogenic response of B cells 
centration of su-  Antigens present in B-cell  to 




P  supernate  R supernate 
TT,  63,130  872  72.4 
TT,  DT  56,340  795  70.9 
TT, Monilia  64,470  853  75.1 
TT,  SKSD  58,550  922  63.5 
TT,  DT,  SKSD,  Monilia  55,610  816  67.6 
TT, KLH  54,290  781  69.5 
TT,  4,895  762  6.42 
TT,  DT  7,312  745  9.81 
TT,  Monilia  7,833  703  11.14 
TT, SKSD  7,105  691  10.28 
TT,  DT,  SKSD,  Monilia  8,246  728  11.3 
TT, KLH  4,756  732  6.49 
* B-cell donors were immune to TT,  DT,  Monilia, and SKSD but not to KLH. 
antigen-specific helper factors described to date are restricted in their activity to 
syngeneic B cells or to B cells that share Ia determinants with the T cells that 
generated  the  factor  (5,  6,  13). Initial  studies  of the  IgG secreted by B  cells 
activated with LMF-TT demonstrated that only a small fraction of that IgG (10- 
20%) had specificity against TT. The rest of the IgG could have been the result of 
polyclonal  B-cell  activation  or  could  have  consisted  of low  affinity  anti-TT 
antibody not detectable by our methods.  The availability of three donors who 
had never been immunized  with TT provided the  opportunity to resolve this 
issue. The sera of these donors lacked hemagglutinating activity against sheep 
erythrocytes coated with TT and their lymphocytes failed to transform in vitro 
when  incubated  with  TT  antigen.  LMF-TT  caused  the  B  cells  of these  TT 
nonimmune donors to synthetize DNA and to secrete IgG in normal amounts as 
compared to B cells from TT-immune donors. However, anti-TT activity was not 
detected in the culture supernates of B cells from TT-nonimmune donors. 
Nonantigen-specific  helper  factors  behave  as  polyclonal  B-cell  activators. 
They trigger B cells in the presence as well as in the absence of antigen  (3, 14, 
15).  LMF-TT containing  supernates  were depleted of TT by passage  through 
anti-TT immunosorbent columns. TT-depleted supernates caused the same de- 
gree of DNA and IgG synthesis in  B  cells as antigen  containing  supernates. 
However,  B  cells  activated  with  TT-depleted  supernates  made  no  detectable 
anti-TT antibodies (Table II). Addition of TT antigen to these supernates after 
their passage through anti-TT immunosorbent columns restored their ability to 
induce anti-TT synthesis by B cells of immune donors. 
Similar results were obtained by using LMF-TT purified on Sephadex G 200. 
LMF activity elutes on Sephadex G 200 after albumin (LMF-TT fraction IV) free 
of both TT and of TT complexed to the anti-TT which is present in the normal 
AB + serum used in the culture medium.  LMF-TT  (fraction IV) induced DNA 
and  IgG synthesis in  B  cells but no  anti-TT  synthesis.  Synthesis  of anti-TT 1444  THE  SPECIFICITY  OF  T-CELL  HELPER  FACTOR  IN  MAN 
TABLE  VII 
Response of B-Cell Cultures Enriched for Antigen-Binding Cells 
Source of  Concentration 
B Cells  MI 
supernate  of supornate 
Response of  B-cell cultures IgG syn- 
thesis* 
Total IgG  anti-TT  anti-DT 
A(P-R) 14C cpm  A(P-R) 125I  cpm 
% 
Untreated  LMF-TT  50  106.3  10,040  4,082  148 
5  2.1  2,336  4,635  39 
LMF-DT  50  58.4  7,065  121  2,316 
5  2.0  1,822  62  2,064 
Cells  binding  to  LMF-TT  50  88.7  9,370  11,230  153 
TT-Sepharose  5  34.5  6,884  13,780  166 
LMF-DT  50  22.3  6,551  1,406  248 
5  1.8  906  189  203 
Cells  eluting  from  LMF-TT  50  93.6  8,860  393  -  71 
TT-Sepharose  5  2.8  1,163  351  80 
LMF-DT  50  47.2  6,071  103  1,941 
5  1.5  1,418  -  24  2,122 
* IgG synthesis was determined on 0.  l-ml portions from supornates of  B-cell  cultures containing 4 
× 106 cells/ml and therefore correspond to the IgG secreted by 4 × 10  s B cells. 
occurred only if TT were added to LMF-TT (fraction IV).  Passage of LMF-TT 
(fraction IV) over either TT or anti-TT immunosorbent columns did not result in 
loss of its activity. Furthermore,  LMF was shown not to contain/z- or ~/-heavy 
chain determinants because passage of LMF (fraction IV) over anti-/z or anti-7 
chain immunosorbents did not affect its activity. The failure of TT and anti-TT 
immunosorbents to remove LMF activity provides further evidence that LMF is 
nonspecific because such immunosorbents are known to remove the activity of 
antigen specific factors (16). 
The synthesis of anti-TT antibody only in the presence of TT antigen can be 
explained in one of two ways. The supernates under study contained in addition 
to the nonspecific helper factor an antigen-specific helper factor which expresses 
its activity only in the presence of antigen. Alternatively, the nonspecific helper 
factor preferentially activates B cells that bind antigen.  That the second possi- 
bility  exists  was  demonstrated  by the  ability  of LMF-TT  to  induce  specific 
antibody synthesis to a second antigen added to the B-cell cultures provided the 
B cells were immune to that second antigen.  Addition of DT to B cells incubated 
with  LMF-TT  resulted  in  the  synthesis  of specific  anti-DT  antibodies  while 
addition of KLH did not result in the synthesis of anti-KLH antibodies (Table 
IV).  In  this  instance  B-cell  donors  were  immune  to  DT  but  not  KLH.  This 
finding was not peculiar to LMF-TT, but occurred with LMF-DT as well. The 
ability of nonspecific helper factors to induce antibody synthesis to antigen that 
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documented in the mouse  (I, 3, 17).  Recently, supernates of human  T  cells 
activated with pokeweed mitogen were shown to  induce human B cells  to  form 
plaque-forming cells  against sheep erythrocytes (18,  19). 
Preferential  triggering of  antigen binding B cells  was seen when low concen- 
trations of LMF-TT  containing supernates were used (Fig. 1). At these low 
concentrations (<10% LMF-TT) total  IgG synthesis dropped much more than 
anti-TT synthesis and the proportion of  anti-TT over  total  IgG synthesized  by B 
cells  increased up  to  70% (Fig.  2).  These findings  are  similar  to  those  obtained  by 
Coutinho and M~ller (!9-21) with submitogenic concentrations of lipopolysac- 
charide a mouse polyclonal B-cell  activator.  Our observations can, however, be 
explained by the simultaneous presence in our T-cell  supornates of  an antigen- 
specific  factor  whose activity  dilutes less  readily than that of the nonspecific 
helper factor.  The latter  alternative is  unlikely to  have occurred in the present 
set of experiments as allogeneic B  cells  were used throughout. Under such 
conditions,  antigen-specific  factors  are unlikely to  be active  because their  activ- 
ity would be restricted  to B cells  that are histocompatible or that share Ia-like 
antigens with the T cells  that made the factors  (5, 6, 13).  It  is,  however, known 
that T cells  stimulated with antigen can secrete simultaneously both antigen- 
specific  as well as antigen nonspecific helper factors  into  their  supernates (21, 
22).  The present experiments do not,  therefore,  rule out  the  presence of  antigen- 
specific  helper  factor(s)  in  the supernates under study. Use of  autologous B cells 
would be necessary to investigate the presence of antigen-specific  factors in 
these supernates. 
The preferential activation of antigen-binding B  cells  by LMF  is further 
illustrated  in  the experiments described in  Table VI and VII.  At low concentra- 
tions  of  LMF-TT  (10%) addition to  the B-cell  cultures of  antigen(s) to  which the 
B-cell  donor is  immune resulted in  an increment in  the extent of  [3H]thymidine 
incorporated into  DNA  (Table  VI).  Furthermore, concentrations of  LMF-TT that 
were submitogenic for  unfractionated B cells  (5%) induced DNA, IgG, and anti- 
TT synthesis in  B-cell  populations that  were enriched in  cells  capable of  binding 
to  TT (Table VII).  This phenomenon was not  due to  nonspecific  activation  of  the 
B cells  during their  enrichment over TT immunosorbent columns as these B 
cells  failed  to respond to low concentrations of  LMF-DT. 
B cells  exposed to graded concentrations of  LMF-TT exhibited dose-response 
curves that differed  for DNA  synthesis and for IgG synthesis (Fig.  1). Optimal 
mitogenic concentrations of  LMF  was 50% LMF  in fresh culture medium while 
the optimum concentration of LMF  for IgG synthesis was 20%. These results 
correlated  with morphologic evidence obtained  by electron  micrographic exami- 
nation of  the cell  pellets.  Maximal number of  plasma cells  were found in B-cell 
pellets  incubated in 10% LMF while  lymphoblasts as  well as  mitotic  figures  were 
most abundant in pellets  incubated with 50% LMF  (Table V). These observa- 
tions raise the possibility  that there are two nonspecific helper factors,  one 
causing mitogenesis and the other causing IgG synthesis in B cells.  Alterna- 
tively  one could be dealing with only one factor  which causes mitogenesis in a 
subpopulation of  B cells  and IgG synthesis and secretion  in a second subpopula- 
tion of B  cells with the latter subpopulation having a lower threshold  of 
response. That certain  B-cell  activators  selectively  trigger  B-cell  subpopulations 
into blastogenesis and/or Ig synthesis is well documented in the mouse model 1446  THE  SPECIFICITY  OF  T-CELL  HELPER  FACTOR  IN  MAN 
(24-26).  Resolution of this question in man will have to await chemical purifica- 
tion of LMF. 
Summary 
Supernates of human T cells stimulated with TT antigen contain a factor that 
induces mitogenesis and immunoglobulin synthesis in autologous as well as 
allogeneic B cells. A fraction of  the IgG produced has specificity against TT. The 
T-cell-derived LMF-TT eluted after albumin on Sephadex G  200  and did not 
contain immunoglobulin heavy chain determinants. LMF-TT was active on B 
cells from TT immune as well as TT-nonimmune individuals but in the latter 
instance the IgG secreted had no specificity against TT. B cells incubated with 
LMF-TT in the presence of  a second antigen (DT) made IgG with specifity to that 
antigen provided the B-cell donor was immune to that second antigen. 
LMF-TT-containing supernates were depleted of TT antigen by Sephadex G 
200 chromatography followed by passage over anti-TT immunosorbent columns. 
The antigen-free supernates were able to induce mitogenesis and IgG synthesis 
in B cells but the IgG produced failed to exhibit specificity against TT unless the 
TT antigen was readded to the B-cell cultures, 
The optimal concentration of LMF-TT (50%) inducing B-cell mitogenesis was 
different from the optimal concentration (20%) causing IgG synthesis by B cells. 
At low LMF concentrations (- 10%) addition of  a second antigen to which the cell 
donor was  immune caused  an  increase  in the  degree  of B-cell  mitogenesis. 
Submitogenic concentrations of LMF-TT (-<5%) were still capable of inducing 
immunoglobulin synthesis in B cells At these low concentrations of LMF-TT the 
proportion of anti-TT IgG over total IgG increased sharply. 
B cells from TT immune donors were separated on TT immunosorbent col- 
umns. Cells that bound to the column were more sensitive to the mitogenic and 
IgG synthetic effects of LMF-TT than unfractionated B cells. 
Thus, LMF is a nonspecific human T-cell helper factor which behaves like a 
polyclonal B-cell activator. However, in the presence of  specific antigen (TT) the 
antigen-specific B  cell is preferentially triggered by LMF. The  experimental 
design of the present  study does not rule  out the  additional presence  of an 
antigen-specific helper factor in the supernates of TT-stimulated human T cells. 
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